Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

BioStock: Curasight presents brain cancer results at World Molecular Imaging Congress

Curasight

Curasight resently presented results from the phase II study with uTRACE in brain cancer at the 2023 World Molecular Imaging Congress held in Prague. The study reveals promising data on the effectiveness of uTRACE and thereby also the potential for uTREAT in treating high-grade gliomas. BioStock contacted CEO Ulrich Krasilnikoff to learn more about the results.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/09/curasight-presents-brain-cancer-results-at-world-molecular-imaging-congress/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.